Inventor · disambiguated record
Steven M. Tracy
Also filed as: TRACY STEVEN · TRACY STEVEN M
5 granted patents·4 pending applications·33 citations·filing 1997–2024
76Inventor score
Top patents by PatentIndex Score
9 records- 0181US11351153B2Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agentUNIV NEBRASKA·Filed 2017·Granted Jun 7, 2022·2 cites·21 claims
- 0279US2025017904A1Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agentUNIV NEBRASKA·Filed 2024·Application pending·0 cites
- 0375US12102617B2Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agentUNIV NEBRASKA·Filed 2022·Granted Oct 1, 2024·0 cites·11 claims
- 0464US6071742ACoxsackie virus as a vector for delivery of anti-inflammatory cytokinesUNIV NEBRASKA·Filed 1997·Granted Jun 6, 2000·23 cites·18 claims
- 0546US6323024B1Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic productsUNIV NEBRASKA·Filed 1998·Granted Nov 27, 2001·8 cites·30 claims
- 0644US2013243847A1Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and use thereofUNIV NEBRASKA·Filed 2013·Application pending·0 cites
- 0739US2003190329A1Coxsackievirus vectors and their use in prevention and treatment of diseaseFiled 2001·Application pending·0 cites
- 0838US2010215707A1Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereofMCDONALD THOMAS·Filed 2010·Application pending·0 cites
- 0925US7189401B1Live attenuated viruses for use as vectors or vaccinesUNIV NEBRASKA·Filed 1999·Granted Mar 13, 2007·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Steven M. Tracy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →